To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPS6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
480 representative clones for gene RPS6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR984681 T-Lymphocytes .a 1 to 797 1 to 799 L7X S247V E248* tiling clone,   799/800
(99 %)
3 diff
(99.7 %id)
BQ227416 embryonal carcinoma, cell line, testis .a 2 to 795 1 to 795   tiling clone,   795/803
(99 %)
3 diff
(99.7 %id)
BI117805 lung, small cell carcinoma .a 7 to 786 1 to 780       780/781
(99 %)
10 diff
(98.8 %id)
BM771801 Ascites, stomach .a 18 to 174 1 to 161       161/161
(100 %)
16 diff
(90.1 %id)
BM263076 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 33 to 636 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BQ350423 head_neck .a 33 to 450 427 to 6       422/427
(98 %)
1 diff
(99.8 %id)
CN396966 embryonic stem cells, cell lines H1, H7, andH9 .a 33 to 503 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BE873947 large cell carcinoma, undifferentiated, lung .a 33 to 793 1 to 754       754/906
(83 %)
28 diff
(97.0 %id)
CD246470 embryonic stem cells, WA01, passage 38 .b 1 to 830 23 to 859   tiling clone,   837/882
(94 %)
21 diff
(97.7 %id)
CR599051 B cells (Ramos cell line) .b 26 to 879 1 to 854 exact     854/854
(100 %)
0 diff
(100 %id)
BX462341 B cells (Ramos cell line) .b 26 to 879 1 to 854 Q248Z fully sequenced,   854/854
(100 %)
2 diff
(99.8 %id)
FE192951   .b 43 to 432 1 to 390       390/390
(100 %)
5 diff
(98.8 %id)
TI_44168971   .b 43 to 689 78 to 725       648/725
(89 %)
9 diff
(98.8 %id)
CR596234 thymus .b 44 to 879 1 to 836 exact     836/836
(100 %)
0 diff
(100 %id)
TI_154182266   .b 47 to 746 101 to 801       701/859
(81 %)
17 diff
(98.1 %id)
TI_154182274   .b 47 to 743 103 to 798       696/827
(84 %)
17 diff
(98.0 %id)
BJ990242 hepatoblastoma .b 50 to 618 1 to 569   fully sequenced,   569/569
(100 %)
0 diff
(100 %id)
NM_001010.2   .b 50 to 878 1 to 829 exact RefSeq,   829/829
(100 %)
0 diff
(100 %id)
AK291517   .b 51 to 1032 1 to 982 exact tiling clone,   982/982
(100 %)
0 diff
(100 %id)
TI_45216729   .b 51 to 718 126 to 791       666/791
(84 %)
8 diff
(99.0 %id)
DA733755   .b 52 to 529 2 to 481   fully sequenced, capped   480/480
(100 %)
3 diff
(99.4 %id)
DB293052   .b 52 to 618 2 to 568   fully sequenced, capped   567/567
(100 %)
0 diff
(100 %id)
AK311861 brain .b 53 to 841 1 to 789 exact     789/789
(100 %)
0 diff
(100 %id)
CR591028 Neuroblastoma Cot 10-normalized .b 55 to 878 1 to 824 exact     824/824
(100 %)
0 diff
(100 %id)
CR591702 placenta .b 55 to 879 1 to 825 exact     825/825
(100 %)
0 diff
(100 %id)
CR593216 Neuroblastoma Cot 10-normalized .b 55 to 879 1 to 825 exact     825/825
(100 %)
0 diff
(100 %id)
CR606554 Placenta Cot 25-normalized .b 55 to 879 1 to 825 exact     825/825
(100 %)
0 diff
(100 %id)
CR608904 Placenta Cot 25-normalized .b 55 to 879 1 to 825 exact     825/825
(100 %)
0 diff
(100 %id)
CR623758 Placenta Cot 25-normalized .b 55 to 879 1 to 825 exact     825/825
(100 %)
0 diff
(100 %id)
CR624791 fetal brain .b 55 to 863 1 to 809 exact     809/809
(100 %)
0 diff
(100 %id)
TI_57151100   .b 56 to 860 58 to 872 R87X R88E T89N G90W E91R ... AAA   793/1011
(78 %)
19 diff
(98.2 %id)
TI_57235405   .b 56 to 743 21 to 708       688/708
(97 %)
7 diff
(99.1 %id)
AW263873 carcinoma in situ from retromolar trigone .b 59 to 439 5 to 385   AAA Submitted on the opposite strand 381/404
(94 %)
8 diff
(98.1 %id)
TI_57187855   .b 59 to 746 57 to 749       693/803
(86 %)
15 diff
(98.2 %id)
TI_154046389   .b 59 to 878 891 to 76 K2E N56T D57T K58N Q59K ... AAA   816/999
(81 %)
5 diff
(99.5 %id)
BM554282 amelanotic melanoma, cell line, skin .b 60 to 878 1 to 819 exact AAA   819/819
(100 %)
0 diff
(100 %id)
BM562459 amelanotic melanoma, cell line, skin .b 60 to 878 1 to 822 Q225P Q227T I228N A229C K230E ... AAA   822/822
(100 %)
11 diff
(98.7 %id)
TI_59384882   .b 60 to 696 65 to 702       638/650
(98 %)
3 diff
(99.6 %id)
CR591444 Neuroblastoma Cot 25-normalized .b 61 to 879 1 to 819 exact     819/819
(100 %)
0 diff
(100 %id)
CR611834 HeLa cells Cot 25-normalized .b 61 to 879 1 to 819 exact     819/819
(100 %)
0 diff
(100 %id)
AL555707 placenta .b 61 to 879 1 to 819 exact     819/819
(100 %)
0 diff
(100 %id)
BI256206 cervical carcinoma cell line, cervix .b 61 to 879 1 to 825 L212T L213F A214G K215Q R216E ... AAA   825/835
(98 %)
14 diff
(98.4 %id)
BM051442 eye, normal pigmented retinal epithelium .b 61 to 695 1 to 641       638/820
(77 %)
14 diff
(98.3 %id)
BU541478 carcinoma, cell line, Prostate .b 61 to 874 1 to 814 exact AAA   814/819
(99 %)
2 diff
(99.8 %id)
TI_57168686   .b 61 to 742 32 to 717       686/717
(95 %)
12 diff
(98.4 %id)
BC071907 Muscle, rhabdomyosarcoma .b 62 to 878 1 to 817 exact available from MGC, AAA   817/817
(100 %)
0 diff
(100 %id)
BC071908 Pancreas, epithelioid carcinoma .b 62 to 878 1 to 817 exact available from MGC, AAA   817/817
(100 %)
0 diff
(100 %id)
CN485103 eye .b 62 to 684 1 to 623       623/623
(100 %)
1 diff
(99.9 %id)
BF683932 leiomyosarcoma cell line, uterus .b 62 to 884 1 to 843 K201T N202T K203I E204H A206E ...     843/997
(84 %)
68 diff
(93.2 %id)
BF684038 leiomyosarcoma cell line, uterus .b 62 to 878 1 to 820 K201T N202T K203I E204K A206E ... AAA   820/1021
(80 %)
16 diff
(98.5 %id)
BG754437 B-cells, primary B-cells from tonsils (cell line) .b 62 to 878 1 to 816 A229G K230R R231D R232A R233D ... AAA   816/816
(100 %)
2 diff
(99.8 %id)
BI261897 lymph, lymphoma, cell line .b 62 to 869 1 to 801 R191V I192L A193L L194* fully sequenced,   801/801
(100 %)
12 diff
(98.6 %id)
BM563882 astrocytoma grade IV, cell line, brain .b 62 to 878 1 to 817 E222D AAA   817/817
(100 %)
2 diff
(99.8 %id)
BM043416 carcinoma, cell line, Prostate .b 62 to 878 1 to 823 A206G L212T A214G K215Q R216E ... AAA   823/823
(100 %)
13 diff
(98.5 %id)
BM552954 amelanotic melanoma, cell line, skin .b 62 to 880 1 to 819 K211T     819/839
(97 %)
5 diff
(99.5 %id)
BM803832 leiomyosarcoma, uterus .b 62 to 877 1 to 815 A220G K221*     815/833
(97 %)
6 diff
(99.3 %id)
BQ946194 leiomyosarcoma, uterus .b 62 to 878 1 to 818 K211X E219X S246I     818/822
(99 %)
7 diff
(99.2 %id)
TI_57187107   .b 62 to 873 31 to 841 N202T K203*     811/811
(100 %)
15 diff
(98.2 %id)
TI_57187957   .b 62 to 693 72 to 707       636/658
(96 %)
22 diff
(96.7 %id)
TI_57193293   .b 62 to 876 55 to 869 K218T I228M A229R K230R R231D ...     815/883
(92 %)
6 diff
(99.4 %id)
TI_59384301   .b 62 to 687 59 to 691       633/633
(100 %)
15 diff
(97.7 %id)
TI_59384683   .b 62 to 740 65 to 743       679/679
(100 %)
0 diff
(100 %id)
TI_59381159   .b 62 to 694 101 to 745   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 645/809
(79 %)
17 diff
(97.9 %id)
TI_59392989   .b 62 to 878 89 to 902 K201N N202K K203* AAA   814/814
(100 %)
8 diff
(99.1 %id)
TI_59390252   .b 62 to 760 101 to 799       699/884
(79 %)
14 diff
(98.5 %id)
TI_59391037   .b 62 to 878 102 to 916 E165R G166R K167*     815/823
(99 %)
14 diff
(98.3 %id)
CT002446 T-Lymphocytes .b 62 to 878 1 to 816 Q248X K249X AAA   816/816
(100 %)
5 diff
(99.4 %id)
CR984339 T-Lymphocytes .b 62 to 874 1 to 815 K230X R233X K243X Q248X AAA   815/820
(99 %)
4 diff
(99.6 %id)
TI_154141633   .b 62 to 698 79 to 716       638/776
(82 %)
17 diff
(97.9 %id)
TI_154143380   .b 62 to 588 80 to 607       528/568
(92 %)
26 diff
(95.5 %id)
CR599282 thymus .b 63 to 879 1 to 817 exact     817/817
(100 %)
0 diff
(100 %id)
CR615680 T cells (Jurkat cell line) .b 63 to 877 1 to 815 exact     815/815
(100 %)
0 diff
(100 %id)
BX415106 thymus .b 63 to 879 1 to 819 W45* fully sequenced,   817/817
(100 %)
4 diff
(99.6 %id)
R07814 liver and spleen .b 63 to 372 8 to 319       312/320
(97 %)
12 diff
(96.3 %id)
BG025339 lymph, lymphoma, cell line .b 63 to 700 1 to 639   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 639/640
(99 %)
7 diff
(99.0 %id)
BG030160 breast, mammary adenocarcinoma, cell line .b 63 to 700 1 to 639       639/641
(99 %)
4 diff
(99.4 %id)
BG685250 B-cells, primary B-cells from tonsils (cell line) .b 63 to 876 1 to 819 N202T K203S E204H A206E E208A ...     819/819
(100 %)
16 diff
(98.1 %id)
BG822941 adenocarcinoma cell line, colon .b 63 to 878 1 to 829 N202T K203*     829/847
(97 %)
16 diff
(98.2 %id)
BI262005 lymph, lymphoma, cell line .b 63 to 829 769 to 1       769/769
(100 %)
3 diff
(99.7 %id)
BM556811 amelanotic melanoma, cell line, skin .b 63 to 878 1 to 817 exact AAA   817/817
(100 %)
4 diff
(99.6 %id)
BM555137 amelanotic melanoma, cell line, skin .b 63 to 878 1 to 816 N163X L213F A214G K215Q K221X ... AAA   816/816
(100 %)
4 diff
(99.6 %id)
BM560951 amelanotic melanoma, cell line, skin .b 63 to 878 1 to 820 K200Q A214G K230Q R231E R232T ...     820/1117
(73 %)
22 diff
(98.1 %id)
BM561305 amelanotic melanoma, cell line, skin .b 63 to 879 1 to 823 E226G Q227T I228N A229C K230E ...     823/1080
(76 %)
11 diff
(99.0 %id)
BM559690 amelanotic melanoma, cell line, skin .b 63 to 877 1 to 815 E226X     815/821
(99 %)
2 diff
(99.8 %id)
BM552486 astrocytoma grade IV, cell line, brain .b 63 to 877 1 to 816 Q227T     816/1024
(79 %)
10 diff
(99.1 %id)
BM552488 astrocytoma grade IV, cell line, brain .b 63 to 878 1 to 816 exact AAA   816/816
(100 %)
3 diff
(99.7 %id)
BM551687 astrocytoma grade IV, cell line, brain .b 63 to 878 1 to 816 exact     816/822
(99 %)
2 diff
(99.8 %id)
BM423344 amelanotic melanoma, cell line, skin .b 63 to 878 1 to 820 exact     820/1089
(75 %)
7 diff
(99.4 %id)
BM927355 lymph, lymphoma, cell line .b 63 to 877 1 to 815 exact     815/816
(99 %)
2 diff
(99.8 %id)
BQ054883 lymph, lymphoma, cell line .b 63 to 878 1 to 817 A206G A207C E208R Y209I A210C ...     817/837
(97 %)
7 diff
(99.2 %id)
BQ056865 lymph, lymphoma, cell line .b 63 to 878 1 to 816 exact AAA   816/816
(100 %)
5 diff
(99.4 %id)
BQ064368 lymph, lymphoma, cell line .b 63 to 878 1 to 816 exact AAA   816/816
(100 %)
1 diff
(99.9 %id)
BQ065471 lymph, lymphoma, cell line .b 63 to 878 1 to 818 A207G E208R Y209I A210C K211* AAA   818/818
(100 %)
16 diff
(98.1 %id)
BQ065764 lymph, lymphoma, cell line .b 63 to 878 1 to 820 R232P S235F S236L L237S R238A ...     820/1026
(79 %)
10 diff
(99.1 %id)
BQ066518 lymph, lymphoma, cell line .b 63 to 877 1 to 820 S235F S236L L237S R238A A239S ...     820/1011
(81 %)
13 diff
(98.8 %id)
BQ066538 lymph, lymphoma, cell line .b 63 to 877 1 to 814 K218X     814/825
(98 %)
4 diff
(99.6 %id)
BQ052206 blood, natural killer cells, cell line .b 63 to 878 1 to 824 A214G M217N K218E E219G A220G ...     824/1082
(76 %)
21 diff
(98.1 %id)
BQ674145 epidermoid carcinoma, cell line, salivary gland .b 63 to 878 1 to 817 E219X K221X AAA   817/817
(100 %)
2 diff
(99.8 %id)
BQ673343 epidermoid carcinoma, cell line, salivary gland .b 63 to 878 1 to 818 K223N R224P S246F S247Q     818/955
(85 %)
13 diff
(98.7 %id)
BQ670605 epidermoid carcinoma, cell line, salivary gland .b 63 to 878 1 to 817 K223N     817/904
(90 %)
8 diff
(99.2 %id)
BQ643201 lymph, lymphoma, cell line .b 63 to 876 1 to 817 A210X K211*     817/956
(85 %)
12 diff
(98.8 %id)
BQ949405 large cell carcinoma, lung .b 63 to 878 1 to 816 exact AAA   816/816
(100 %)
3 diff
(99.7 %id)
BQ941486 large cell carcinoma, lung .b 63 to 876 1 to 824 K223Q Q225P E226G Q227N I228K ...     824/948
(86 %)
22 diff
(97.7 %id)
TI_57188657   .b 63 to 742 55 to 740       683/687
(99 %)
8 diff
(98.9 %id)
TI_57192731   .b 63 to 868 119 to 923 Q155S Y156M V157L V158*     805/806
(99 %)
6 diff
(99.3 %id)
AB062123   .b 64 to 878 1 to 815 exact AAA   815/815
(100 %)
0 diff
(100 %id)
AJ712511 bone marrow .b 64 to 438 1 to 372       372/372
(100 %)
47 diff
(87.4 %id)
CN397185 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 64 to 696 1 to 633   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 633/635
(99 %)
2 diff
(99.7 %id)
CR600766 Placenta Cot 25-normalized .b 64 to 879 1 to 816 exact     816/816
(100 %)
0 diff
(100 %id)
AA147782   .b 64 to 512 1 to 446   fully sequenced,   446/446
(100 %)
1 diff
(99.8 %id)
BG026191 Bone, osteosarcoma, cell line .b 64 to 744 1 to 682       682/1104
(61 %)
10 diff
(99.1 %id)
BG390118 embryonal carcinoma, cell line, testis .b 64 to 689 1 to 626       626/626
(100 %)
4 diff
(99.4 %id)
BM913480 amelanotic melanoma, cell line, skin .b 64 to 879 1 to 816 exact     816/823
(99 %)
2 diff
(99.8 %id)
BM916945 blood, natural killer cells, cell line .b 64 to 878 1 to 815 exact AAA   815/815
(100 %)
1 diff
(99.9 %id)
BM458527 lymph, lymphoma, cell line .b 64 to 878 1 to 816 N202Y R216K E222D Q225P Q227P ...     816/1133
(72 %)
21 diff
(98.2 %id)
BM462478 leiomyosarcoma, uterus .b 64 to 879 1 to 817 S247R     817/1030
(79 %)
8 diff
(99.3 %id)
BM454890 leiomyosarcoma, uterus .b 64 to 875 1 to 815 A214G S236L L237S R238A A239S ... AAA   815/818
(99 %)
13 diff
(98.5 %id)
BM555985 duodenal adenocarcinoma, cell line, small intestine .b 64 to 879 1 to 816 K249N     816/822
(99 %)
9 diff
(99.0 %id)
BM470210 lymph, lymphoma, cell line .b 64 to 876 1 to 814 exact AAA   814/816
(99 %)
3 diff
(99.7 %id)
BQ054478 lymph, lymphoma, cell line .b 64 to 877 1 to 815 K211X AAA   815/817
(99 %)
5 diff
(99.4 %id)
BQ277641 ovary, teratocarcinoma, cell line .b 64 to 878 1 to 815 exact AAA   815/815
(100 %)
2 diff
(99.8 %id)
BQ054791 lymph, lymphoma, cell line .b 64 to 879 1 to 817 K201I E226G Q227T I228N A229C ...     817/834
(97 %)
7 diff
(99.2 %id)
BQ056889 lymph, lymphoma, cell line .b 64 to 878 1 to 815 N163X S247R AAA   815/815
(100 %)
2 diff
(99.8 %id)
BQ061662 lymph, lymphoma, cell line .b 64 to 876 1 to 815 Q227T I228N A229C K230E R231K ... AAA   815/817
(99 %)
12 diff
(98.6 %id)
BQ062243 lymph, lymphoma, cell line .b 64 to 877 1 to 816 R216K E219X E226G S235F S246F ...     816/816
(100 %)
10 diff
(98.8 %id)
BQ063582 lymph, lymphoma, cell line .b 64 to 879 1 to 817 K215Q E245G S247R     817/1045
(78 %)
13 diff
(98.8 %id)
BQ066824 lymph, lymphoma, cell line .b 64 to 878 1 to 815 Q248P AAA   815/815
(100 %)
2 diff
(99.8 %id)
BQ276297 carcinoma, cell line, Prostate .b 64 to 878 1 to 815 exact     815/815
(100 %)
1 diff
(99.9 %id)
BQ220500 large cell carcinoma, lung .b 64 to 878 1 to 815 exact AAA   815/815
(100 %)
2 diff
(99.8 %id)
BQ437580 eye, retinoblastoma .b 64 to 878 1 to 816 K215Q K221X E226G AAA   816/816
(100 %)
4 diff
(99.6 %id)
BU191083 melanotic melanoma, cell line, skin .b 64 to 878 1 to 816 S246I AAA   816/816
(100 %)
4 diff
(99.6 %id)
BQ676866 melanotic melanoma, cell line, skin .b 64 to 878 1 to 815 exact AAA   815/815
(100 %)
2 diff
(99.8 %id)
BQ882733 lymph, lymphoma, cell line .b 64 to 878 1 to 824 L212P L213F A214G K215Q R216E ...     824/948
(86 %)
20 diff
(97.9 %id)
BQ955142 large cell carcinoma, lung .b 64 to 876 1 to 816 K200Q E219G E226V A229L K230R ...     816/922
(88 %)
16 diff
(98.3 %id)
BQ955153 large cell carcinoma, lung .b 64 to 878 1 to 822 K196E Q197A R198A T199Y K200Q ...     822/933
(88 %)
22 diff
(97.7 %id)
BU537977 adenocarcinoma, cell line, breast .b 64 to 879 1 to 817 K215Q K243*     817/832
(98 %)
12 diff
(98.6 %id)
BU541255 carcinoma, cell line, Prostate .b 64 to 878 1 to 815 exact AAA   815/815
(100 %)
0 diff
(100 %id)
BU955940 adenocarcinoma, cell line, breast .b 64 to 868 1 to 817 E219X A220G K221*     817/942
(86 %)
23 diff
(97.6 %id)
TI_149298846   .b 64 to 878 901 to 90 K2S L3* AAA   812/936
(86 %)
7 diff
(99.3 %id)
CN397096 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 65 to 696 1 to 632   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 632/634
(99 %)
2 diff
(99.7 %id)
EL947254 eyeball .b 65 to 387 1 to 322       322/322
(100 %)
7 diff
(97.9 %id)
AW673598 cervix .b 65 to 409 1 to 345   fully sequenced,   345/345
(100 %)
0 diff
(100 %id)
BG112046 Bone, osteosarcoma, cell line .b 65 to 703 1 to 638       638/638
(100 %)
8 diff
(98.8 %id)
BG822760 adenocarcinoma cell line, colon .b 65 to 879 1 to 816 K201N N202T K203T E208R Y209I ...     816/972
(83 %)
16 diff
(98.4 %id)
BI259670 cervical carcinoma cell line, cervix .b 65 to 876 1 to 814 R232T R233Q L234T S235F S236L ... AAA   814/816
(99 %)
5 diff
(99.4 %id)
BM801787 duodenal adenocarcinoma, cell line, small intestine .b 65 to 873 1 to 816 K203X L234T S235F S236L L237S ...     816/840
(97 %)
10 diff
(98.9 %id)
BQ438092 leiomyosarcoma, uterus .b 65 to 879 1 to 815 exact     815/823
(99 %)
3 diff
(99.7 %id)
BQ932349 sciatic nerve .b 65 to 879 1 to 816 exact     816/824
(99 %)
5 diff
(99.4 %id)
BQ887674 eye, retinoblastoma .b 65 to 878 1 to 824 K211T S235F S236L L237S R238A ...     824/935
(88 %)
22 diff
(97.7 %id)
BQ961371 leiomyosarcoma, uterus .b 65 to 879 1 to 815 S246I     815/822
(99 %)
5 diff
(99.4 %id)
TI_59385680   .b 65 to 740 65 to 746       682/683
(99 %)
14 diff
(98.0 %id)
BY995118   .b 65 to 727 34 to 696       663/696
(95 %)
6 diff
(99.2 %id)
BY995134   .b 65 to 726 37 to 698       662/698
(94 %)
6 diff
(99.2 %id)
AJ713111 bone marrow .b 66 to 374 1 to 308       308/308
(100 %)
2 diff
(99.4 %id)
BC094826 Skin, melanoma, amelanotic .b 66 to 878 1 to 813 exact AAA   813/813
(100 %)
0 diff
(100 %id)
AI623754 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 66 to 689 623 to 1       623/623
(100 %)
13 diff
(98.0 %id)
BQ278724 adenocarcinoma, cell line, breast .b 66 to 880 1 to 819 S246I S247Q Q248S K249E     819/1104
(74 %)
12 diff
(99.0 %id)
BQ065523 lymph, lymphoma, cell line .b 66 to 874 1 to 812 S247R Q248S K249E AAA   812/817
(99 %)
7 diff
(99.2 %id)
BQ949649 large cell carcinoma, lung .b 66 to 878 1 to 817 E222G K223E R224A Q225P E226G ... AAA   817/817
(100 %)
10 diff
(98.8 %id)
BQ934613 large cell carcinoma, lung .b 66 to 879 1 to 820 Q225P E226G Q227P A229G K230E ...     820/988
(82 %)
22 diff
(97.8 %id)
TI_57186149   .b 67 to 858 55 to 847 I228M A229G K230R R231D R232A ...     793/863
(91 %)
6 diff
(99.4 %id)
TI_59388714   .b 67 to 695 106 to 740   AAA   635/815
(77 %)
16 diff
(98.1 %id)
CR591066 Placenta Cot 25-normalized .b 68 to 879 1 to 812 exact     812/812
(100 %)
0 diff
(100 %id)
CR600949 Neuroblastoma Cot 10-normalized .b 68 to 879 1 to 812 exact     812/812
(100 %)
0 diff
(100 %id)
CR606866 placenta .b 68 to 879 1 to 812 exact     812/812
(100 %)
0 diff
(100 %id)
CR612567 fetal liver .b 68 to 879 1 to 812 exact     812/812
(100 %)
0 diff
(100 %id)
BX405801 fetal liver, Liver .b 68 to 879 1 to 812 exact fully sequenced,   812/812
(100 %)
0 diff
(100 %id)
AA113751   .b 68 to 482 1 to 415   fully sequenced,   415/415
(100 %)
0 diff
(100 %id)
AW630178 2 pooled high-grade transitional celltumors, genitourinary tract .b 68 to 471 1 to 404   fully sequenced,   404/404
(100 %)
0 diff
(100 %id)
TI_57217080   .b 68 to 681 30 to 643       614/643
(95 %)
6 diff
(99.1 %id)
M20020   .b 68 to 879 4 to 814 K23T L144R K196Q     811/814
(99 %)
13 diff
(98.5 %id)
W05844 lung .b 69 to 471 1 to 400   fully sequenced,   400/400
(100 %)
0 diff
(100 %id)
BI860890 breast, mammary adenocarcinoma, cell line .b 69 to 696 1 to 629   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 629/636
(98 %)
3 diff
(99.6 %id)
TI_57229996   .b 69 to 878 76 to 885 K215R R216E M217* AAA   810/810
(100 %)
5 diff
(99.4 %id)
TI_59382242   .b 69 to 743 100 to 776       677/677
(100 %)
4 diff
(99.5 %id)
BM697871 eye, fetal eyes .b 69 to 435 1 to 367   fully sequenced,   367/367
(100 %)
1 diff
(99.8 %id)
BM697850 eye, fetal eyes .b 69 to 260 1 to 192   fully sequenced,   192/192
(100 %)
0 diff
(100 %id)
BM699051 eye, fetal eyes .b 69 to 618 1 to 550   fully sequenced,   550/550
(100 %)
0 diff
(100 %id)
AW327896 Burkitt lymphoma, lymph .b 70 to 471 1 to 402   fully sequenced,   402/402
(100 %)
0 diff
(100 %id)
BI087382 cervix .b 70 to 691 1 to 636       634/896
(70 %)
25 diff
(97.3 %id)
BQ954598 large cell carcinoma, lung .b 70 to 878 1 to 816 E205D K211*     816/981
(83 %)
24 diff
(97.6 %id)
BF663782 B-cells, primary B-cells from tonsils (cell line) .b 71 to 689 1 to 626       624/794
(78 %)
15 diff
(98.2 %id)
BQ644086 hepatocellular carcinoma, cell line, Liver .b 71 to 878 1 to 817 R170X Q225P E226G Q227T I228N ... AAA   817/817
(100 %)
15 diff
(98.2 %id)
AW327832 Burkitt lymphoma, lymph .b 72 to 575 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
EC471997 Prostate .b 77 to 170 7 to 101   AAA   95/101
(94 %)
10 diff
(90.1 %id)
BQ269197 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
BQ776811 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
BQ777399 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
BU072731 Pancreas, Purified pancreatic islet .b 83 to 471 1 to 389   fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
BU072799 Pancreas, Purified pancreatic islet .b 83 to 260 1 to 178   fully sequenced,   178/178
(100 %)
0 diff
(100 %id)
BU076493 Pancreas, Purified pancreatic islet .b 83 to 471 1 to 389   fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
BU785930 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
BU950555 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
CA772348 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
CA941515 Pancreas, Purified pancreatic islet .b 83 to 471 1 to 389   fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
CB069801 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
CA942277 Pancreas, Purified pancreatic islet .b 83 to 471 1 to 389   fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
CA942286 Pancreas, Purified pancreatic islet .b 83 to 471 1 to 389   fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
CA951009 Pancreas, Purified pancreatic islet .b 83 to 618 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
BM565094 insulinoma, Pancreas .b 92 to 618 1 to 527   fully sequenced,   527/527
(100 %)
0 diff
(100 %id)
J03537   .b 92 to 878 1 to 787 Q59X Q155E Y156C K168R E219Q     787/787
(100 %)
6 diff
(99.3 %id)
TI_149293900   .b 92 to 878 854 to 90   AAA   768/922
(83 %)
35 diff
(96.3 %id)
AA394304   .b 96 to 471 8 to 383   fully sequenced,   376/383
(98 %)
6 diff
(98.5 %id)
TI_149290726   .b 96 to 878 864 to 89   AAA   776/969
(80 %)
9 diff
(99.1 %id)
TI_149292180   .b 96 to 878 849 to 69   AAA   781/955
(81 %)
6 diff
(99.4 %id)
TI_154050034   .b 96 to 878 871 to 94   AAA   778/981
(79 %)
6 diff
(99.4 %id)
TI_154060946   .b 96 to 878 868 to 89   AAA   780/960
(81 %)
9 diff
(99.1 %id)
TI_154052860   .b 99 to 878 847 to 88   AAA   762/921
(82 %)
22 diff
(97.7 %id)
TI_158436123   .b 101 to 878 853 to 80   AAA   774/1126
(68 %)
10 diff
(99.2 %id)
BF815928 colon_ins .b 112 to 441 339 to 11     Submitted on the opposite strand 329/571
(57 %)
6 diff
(99.0 %id)
BE164567 head_neck .b 114 to 287 173 to 5     Submitted on the opposite strand 169/173
(97 %)
1 diff
(99.5 %id)
TI_154126534   .b 126 to 878 835 to 83   AAA   753/986
(76 %)
6 diff
(99.4 %id)
Z20365   .b 157 to 413 253 to 4       254/257
(98 %)
5 diff
(98.1 %id)
CR622346 HeLa cells Cot 25-normalized .b 162 to 879 1 to 718       718/718
(100 %)
0 diff
(100 %id)
FN154111 breast carcinoma .b 163 to 261 105 to 1     Submitted on the opposite strand 102/106
(96 %)
5 diff
(95.3 %id)
AW410938.
matches multiple genes
muscle, rhabdomyosarcoma .b 195 to 703 516 to 8   AAA Suspected internal deletion, suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored, also hits gene TMEM150CandRPS6P6 509/516
(98 %)
1 diff
(99.9 %id)
BU737126 eye, fetal eyes .b 199 to 878 696 to 19   fully sequenced, AAA   678/678
(100 %)
2 diff
(99.8 %id)
BU072499 Pancreas, Purified pancreatic islet .b 204 to 876 674 to 2   fully sequenced,   673/674
(99 %)
0 diff
(100 %id)
AI282840 colon, moderately-differentiated adenocarcinoma .b 219 to 688 464 to 1       464/468
(99 %)
11 diff
(97.7 %id)
BC035447 Cervix, carcinoma .b 226 to 878 1 to 653   available from MGC, AAA   653/653
(100 %)
0 diff
(100 %id)
BI009047 kidney_tumor .b 228 to 673 448 to 3       446/484
(92 %)
12 diff
(97.6 %id)
AA886613.
matches multiple genes
metastatic prostate bone lesion .b 242 to 376 1 to 133   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, also hits gene RPS6P10 133/142
(93 %)
6 diff
(95.8 %id)
CV355612 head_neck .b 243 to 692 455 to 6     Submitted on the opposite strand 450/455
(98 %)
5 diff
(99.0 %id)
BQ371306 prostate_normal .b 247 to 673 426 to 1       426/426
(100 %)
5 diff
(98.9 %id)
DV460685 cochlea, ear .b 249 to 685 438 to 1     Submitted on the opposite strand 438/439
(99 %)
3 diff
(99.4 %id)
BE839408 prostate_normal .b 254 to 683 438 to 8       431/438
(98 %)
1 diff
(99.8 %id)
BF848845 lung_normal .b 254 to 664 420 to 11     Submitted on the opposite strand 410/451
(90 %)
0 diff
(100 %id)
BQ356569 head_neck .b 256 to 456 222 to 19       204/222
(91 %)
0 diff
(100 %id)
EC487054 Prostate .b 259 to 368 1 to 110       110/110
(100 %)
0 diff
(100 %id)
EC553626 Prostate .b 262 to 375 114 to 1       114/114
(100 %)
0 diff
(100 %id)
AW803777 uterus .b 263 to 380 122 to 5       118/122
(96 %)
6 diff
(95.1 %id)
EC452240 Prostate .b 264 to 375 112 to 1       112/113
(99 %)
0 diff
(100 %id)
EC545901 Prostate .b 266 to 374 1 to 109       109/109
(100 %)
0 diff
(100 %id)
CA866841 Pancreas, Purified pancreatic islet .b 266 to 879 615 to 2       614/615
(99 %)
0 diff
(100 %id)
BG876905 head_neck .b 284 to 692 432 to 24       409/432
(94 %)
1 diff
(99.8 %id)
BF764040 colon_est .b 285 to 677 393 to 1     Submitted on the opposite strand 393/393
(100 %)
1 diff
(99.8 %id)
BF764041 colon_est .b 294 to 677 384 to 1     Submitted on the opposite strand 384/384
(100 %)
2 diff
(99.5 %id)
BM691451 eye, RPE and Choroid .b 296 to 869 1 to 574   fully sequenced,   574/574
(100 %)
4 diff
(99.4 %id)
GD146654   .b 299 to 369 1 to 71   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 71/73
(97 %)
6 diff
(91.8 %id)
GD155089   .b 299 to 696 1 to 400   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 400/402
(99 %)
18 diff
(95.6 %id)
GD155596   .b 299 to 369 1 to 70   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 70/72
(97 %)
5 diff
(93.1 %id)
GD155877   .b 299 to 369 1 to 70   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 70/72
(97 %)
6 diff
(91.7 %id)
DR978617 brain .b 299 to 369 1 to 69     Submitted on the opposite strand 69/71
(97 %)
6 diff
(91.6 %id)
DR978622 brain .b 299 to 696 1 to 397   AAA Submitted on the opposite strand 397/399
(99 %)
5 diff
(98.8 %id)
GD160660.
matches multiple genes
  .b 302 to 384 1 to 85     also hits gene RPS6P1 85/96
(88 %)
15 diff
(84.4 %id)
GD135632   .b 306 to 376 9 to 76       68/77
(88 %)
5 diff
(93.6 %id)
EH339866   .b 307 to 384 1 to 78       78/78
(100 %)
0 diff
(100 %id)
GD137316   .b 311 to 700 1 to 390   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 390/392
(99 %)
7 diff
(98.3 %id)
AI630373 blood .b 318 to 685 368 to 1       368/368
(100 %)
1 diff
(99.8 %id)
AW731744 cervix .b 379 to 877 501 to 3   fully sequenced,   499/501
(99 %)
0 diff
(100 %id)
AA383770 thyroid gland .b 388 to 492 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
BM667050 eye, fetal eyes .b 405 to 878 492 to 19   fully sequenced, AAA   474/474
(100 %)
0 diff
(100 %id)
N71101 lung .b 410 to 878 469 to 1   fully sequenced,   469/469
(100 %)
1 diff
(99.8 %id)
AA398506   .b 410 to 879 472 to 3   fully sequenced,   470/472
(99 %)
0 diff
(100 %id)
BU072438 Pancreas, Purified pancreatic islet .b 410 to 879 470 to 1   fully sequenced,   470/470
(100 %)
2 diff
(99.6 %id)
BU076242 Pancreas, Purified pancreatic islet .b 410 to 877 468 to 1   fully sequenced,   468/468
(100 %)
0 diff
(100 %id)
CA941222 Pancreas, Purified pancreatic islet .b 410 to 876 469 to 3   fully sequenced,   467/469
(99 %)
0 diff
(100 %id)
CA844068 Pancreas, Purified pancreatic islet .b 410 to 876 468 to 2   fully sequenced,   467/468
(99 %)
0 diff
(100 %id)
CA844077 Pancreas, Purified pancreatic islet .b 410 to 876 468 to 2   fully sequenced,   467/468
(99 %)
0 diff
(100 %id)
AW613588 2 pooled high-grade transitional celltumors, genitourinary tract .b 419 to 878 460 to 1   fully sequenced,   460/460
(100 %)
1 diff
(99.8 %id)
AW327858 Burkitt lymphoma, lymph .b 427 to 878 471 to 20   fully sequenced, AAA   452/452
(100 %)
1 diff
(99.8 %id)
BE839352 prostate_normal .b 446 to 681 241 to 8       234/241
(97 %)
0 diff
(100 %id)
AA113243   .b 452 to 876 427 to 3   fully sequenced,   425/427
(99 %)
0 diff
(100 %id)
FN129280 breast carcinoma .b 467 to 564 103 to 1     Submitted on the opposite strand 103/103
(100 %)
5 diff
(95.2 %id)
BF734018 amnion_normal .b 469 to 682 216 to 4     Submitted on the opposite strand 213/216
(98 %)
1 diff
(99.6 %id)
DR978804 placenta .b 470 to 696 1 to 226   AAA Submitted on the opposite strand 226/228
(99 %)
9 diff
(96.1 %id)
BF800289 colon_ins .b 474 to 683 236 to 25     Submitted on the opposite strand 212/241
(87 %)
8 diff
(96.7 %id)
AA155777   .b 482 to 878 413 to 17   fully sequenced, AAA   397/397
(100 %)
0 diff
(100 %id)
AW796094 uterus .b 498 to 695 212 to 13       200/218
(91 %)
2 diff
(99.1 %id)
DB365738   .b 499 to 878 380 to 1   fully sequenced,   380/380
(100 %)
0 diff
(100 %id)
DV462419 cochlea, ear .b 507 to 685 179 to 1     Submitted on the opposite strand 179/179
(100 %)
0 diff
(100 %id)
DV459346 cochlea, ear .b 507 to 685 179 to 1     Submitted on the opposite strand 179/179
(100 %)
0 diff
(100 %id)
DV459399 cochlea, ear .b 507 to 685 179 to 1     Submitted on the opposite strand 179/184
(97 %)
2 diff
(99.0 %id)
DV459434 cochlea, ear .b 509 to 689 183 to 3     Submitted on the opposite strand 181/183
(98 %)
0 diff
(100 %id)
DV460607 cochlea, ear .b 519 to 688 182 to 13     Submitted on the opposite strand 170/184
(92 %)
0 diff
(100 %id)
AA648684 Ewing's sarcoma .b 526 to 680 154 to 1       154/154
(100 %)
5 diff
(96.8 %id)
BQ325565 colon_ins .b 540 to 689 171 to 26       146/171
(85 %)
0 diff
(100 %id)
BF760687 colon .b 550 to 699 147 to 2     Submitted on the opposite strand 146/150
(97 %)
0 diff
(100 %id)
BX415105 thymus .b 557 to 853 299 to 1   fully sequenced,   299/299
(100 %)
0 diff
(100 %id)
BX455905 B cells (Ramos cell line) .b 557 to 877 321 to 1   fully sequenced,   321/321
(100 %)
0 diff
(100 %id)
BX405800 fetal liver, Liver .b 557 to 869 316 to 1   fully sequenced,   316/316
(100 %)
3 diff
(99.1 %id)
BJ990243 hepatoblastoma .b 557 to 874 318 to 1   fully sequenced,   318/318
(100 %)
0 diff
(100 %id)
BI262417 lymph, lymphoma, cell line .b 557 to 830 274 to 1   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
BM512491 insulinoma, Pancreas .b 557 to 877 353 to 33   fully sequenced, AAA   321/321
(100 %)
1 diff
(99.7 %id)
BQ268924 Pancreas, Purified pancreatic islet .b 557 to 877 321 to 1   fully sequenced,   321/321
(100 %)
0 diff
(100 %id)
BQ776496 Pancreas, Purified pancreatic islet .b 557 to 876 321 to 2   fully sequenced,   320/321
(99 %)
0 diff
(100 %id)
BQ788074 Pancreas, Purified pancreatic islet .b 557 to 876 321 to 2   fully sequenced,   320/321
(99 %)
0 diff
(100 %id)
BU785610 Pancreas, Purified pancreatic islet .b 557 to 879 325 to 3   fully sequenced,   323/325
(99 %)
0 diff
(100 %id)
BU950263 Pancreas, Purified pancreatic islet .b 557 to 878 322 to 1   fully sequenced,   322/322
(100 %)
0 diff
(100 %id)
CA772059 Pancreas, Purified pancreatic islet .b 557 to 879 326 to 4   fully sequenced,   323/326
(99 %)
0 diff
(100 %id)
CB068525 Pancreas, Purified pancreatic islet .b 557 to 876 322 to 3   fully sequenced,   320/322
(99 %)
0 diff
(100 %id)
CA950762 Pancreas, Purified pancreatic islet .b 557 to 876 321 to 2   fully sequenced,   320/321
(99 %)
0 diff
(100 %id)
BM662509 eye, RPE and Choroid .b 557 to 878 339 to 18   fully sequenced, AAA   322/322
(100 %)
0 diff
(100 %id)
BM669353 eye, fetal eyes .b 557 to 876 341 to 21   fully sequenced, AAA   321/323
(99 %)
0 diff
(100 %id)
DB382991   .b 557 to 878 322 to 1   fully sequenced,   322/322
(100 %)
0 diff
(100 %id)
DV460358 cochlea, ear .b 573 to 685 19 to 132       114/132
(86 %)
6 diff
(95.5 %id)
EC456102.
matches multiple genes
Prostate .b 582 to 681 7 to 112     also hits gene RPS6P10 106/112
(94 %)
6 diff
(94.7 %id)
EC533434 Prostate .b 586 to 690 110 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 101/112
(90 %)
0 diff
(100 %id)
EC544097 Prostate .b 586 to 686 104 to 4       101/105
(96 %)
0 diff
(100 %id)
FN168657 breast carcinoma .b 586 to 691 1 to 112       112/112
(100 %)
6 diff
(94.7 %id)
EC443059 Prostate .b 588 to 694 1 to 108       108/108
(100 %)
2 diff
(98.2 %id)
EC486065.
matches multiple genes
Prostate .b 599 to 699 11 to 111     also hits gene RPS6P10 101/111
(90 %)
6 diff
(94.6 %id)
DV460705 cochlea, ear .b 613 to 685 1 to 73       73/73
(100 %)
0 diff
(100 %id)
AV741605 cord Blood .c 1 to 485 45 to 528       489/532
(91 %)
15 diff
(97.2 %id)
BI603449 brain, hypothalamus .c 1 to 779 3 to 787       787/787
(100 %)
20 diff
(97.5 %id)
BU849298 mixed (pool of 40 RNAs) .c 1 to 826 2 to 827 K148X L193X K194E N201I K220X ... tiling clone,   827/839
(98 %)
16 diff
(98.1 %id)
BM465767 eye, retinoblastoma .c 1 to 541 1 to 539       539/1248
(43 %)
43 diff
(96.6 %id)
TI_45212740   .c 4 to 779 86 to 867       782/867
(90 %)
22 diff
(97.5 %id)
EL948637 eyeball .c 15 to 671 1 to 655       655/655
(100 %)
8 diff
(98.8 %id)
BM423790 amelanotic melanoma, cell line, skin .c 22 to 611 1 to 591       590/935
(63 %)
29 diff
(96.9 %id)
BE538439 cervix .c 27 to 531 1 to 521       521/521
(100 %)
21 diff
(96.0 %id)
BE563621 adenocarcinoma, Pancreas .c 53 to 828 1 to 782   tiling clone, AAA   782/782
(100 %)
14 diff
(98.3 %id)
AV750147 Pituitary .c 88 to 458 1 to 366       366/366
(100 %)
9 diff
(97.6 %id)
AV748062 Pituitary .c 89 to 444 1 to 355       355/370
(95 %)
4 diff
(99.0 %id)
ES310304 scalp interfollicular dermis, skin .c 188 to 696 1 to 518       518/554
(93 %)
9 diff
(98.4 %id)
TI_154184306   .c 200 to 812 97 to 713       617/963
(64 %)
20 diff
(98.0 %id)
EL952678 eyeball .c 215 to 737 31 to 563       533/563
(94 %)
5 diff
(99.2 %id)
GD135633   .c 261 to 638 3 to 391   AAA   389/391
(99 %)
19 diff
(95.2 %id)
AI814231 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 268 to 827 560 to 1       560/560
(100 %)
0 diff
(100 %id)
BM955934 tonsil .c 337 to 828 1 to 493   AAA   493/493
(100 %)
1 diff
(99.8 %id)
AV741107 cord Blood .c 338 to 825 14 to 470   AAA   467/472
(98 %)
72 diff
(84.8 %id)
EL948499 eyeball .c 368 to 829 1 to 461   tiling clone,   460/465
(98 %)
8 diff
(98.3 %id)
DA083291 cerebellum .d 1 to 479 2 to 485   capped   484/488
(99 %)
6 diff
(98.8 %id)
DB185038 liver, tumor tissue .d 1 to 437 2 to 438   capped   437/437
(100 %)
0 diff
(100 %id)
DB264743 uterus .d 1 to 538 2 to 539   tiling clone, capped   538/538
(100 %)
0 diff
(100 %id)
CD522599 pooled .d 520 to 1277 1 to 769 K180* tiling clone,   769/885
(86 %)
23 diff
(97.5 %id)
BG422836 Kidney, renal cell adenocarcinoma .e 1 to 764 1 to 766 K167Q L212T L213F A214G K215P ... tiling clone,   766/951
(80 %)
17 diff
(98.3 %id)
AV717663   .f 1 to 705 1 to 704   tiling clone,   704/718
(98 %)
2 diff
(99.8 %id)
AV649154 corresponding non cancerous liver tissue .f 15 to 448 1 to 434     Submitted on the opposite strand 434/434
(100 %)
4 diff
(99.1 %id)
AV649159 corresponding non cancerous liver tissue .f 15 to 386 1 to 372     Submitted on the opposite strand 372/375
(99 %)
2 diff
(99.5 %id)
AV649167 corresponding non cancerous liver tissue .f 15 to 386 1 to 372     Submitted on the opposite strand 372/373
(99 %)
1 diff
(99.8 %id)
AV649191 corresponding non cancerous liver tissue .f 15 to 386 1 to 372     Submitted on the opposite strand 372/372
(100 %)
0 diff
(100 %id)
AV649217 corresponding non cancerous liver tissue .f 15 to 448 1 to 434     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
AV649261 corresponding non cancerous liver tissue .f 15 to 687 1 to 672     Submitted on the opposite strand 672/672
(100 %)
16 diff
(97.7 %id)
AV649301 corresponding non cancerous liver tissue .f 15 to 760 1 to 739     Submitted on the opposite strand 741/762
(97 %)
25 diff
(96.8 %id)
AV649365 corresponding non cancerous liver tissue .f 15 to 386 1 to 372     Submitted on the opposite strand 372/375
(99 %)
1 diff
(99.8 %id)
AV649400 corresponding non cancerous liver tissue .f 15 to 449 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
AV649453 corresponding non cancerous liver tissue .f 15 to 449 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
AV649503 corresponding non cancerous liver tissue .f 15 to 449 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
AV649532 corresponding non cancerous liver tissue .f 15 to 448 1 to 434     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
BQ055430 lymph, lymphoma, cell line .f 15 to 863 1 to 856 S205L L206S R207A A208S S209F ... tiling clone,   856/966
(88 %)
14 diff
(98.6 %id)
BG289310 bladder, transitional cell papilloma, cell line .f 46 to 760 1 to 709   AAA   709/819
(86 %)
8 diff
(99.1 %id)
DA351336 substantia nigra .g 1 to 590 2 to 591   capped   590/590
(100 %)
5 diff
(99.2 %id)
DA020031   .g 3 to 567 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
DA129973 alzheimer cortex .g 4 to 548 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA012757 adrenal gland .g 5 to 565 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA045537 bladder .g 5 to 544 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA203402 brain .g 5 to 594 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA354650 substantia nigra .g 5 to 566 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA392018 thalamus .g 5 to 595 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA520495 brain .g 5 to 583 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA616090   .g 5 to 578 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA635583 Kidney .g 5 to 569 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA805970 brain .g 5 to 594 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA940827 Spleen .g 5 to 594 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA960009 Spleen .g 5 to 548 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA872256 Prostate .g 6 to 539 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA530611 brain .g 7 to 619 2 to 613   capped   612/612
(100 %)
3 diff
(99.6 %id)
DB032513 testis .g 7 to 563 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB275658 uterus .g 7 to 551 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
CX760526 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 18 to 754 1 to 728     Submitted on the opposite strand 728/854
(85 %)
14 diff
(98.4 %id)
CN264151 embryonic stem cells, cell lines H1, H7, andH9 .g 19 to 650 9 to 639       631/639
(98 %)
6 diff
(99.1 %id)
AL538733 brain, fetal brain .g 22 to 481 1 to 460   fully sequenced,   460/460
(100 %)
4 diff
(99.2 %id)
CR611303 fetal brain .g 23 to 1388 1 to 1366 exact tiling clone,   1366/1366
(100 %)
0 diff
(100 %id)
DA230656 brain .g 30 to 602 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB044217 testis .g 30 to 579 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA934936 Spleen .g 33 to 617 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DB183140 liver, tumor tissue .g 34 to 583 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB277813 uterus .g 34 to 572 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA044910 bladder .g 38 to 605 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB163001 thymus .g 38 to 635 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
H17824 whole brain .g 45 to 386 1 to 342       342/342
(100 %)
6 diff
(98.3 %id)
AL567473 brain, fetal brain .g 451 to 1388 935 to 1 A7V D8T A9L L10W G11V ... fully sequenced,   935/935
(100 %)
4 diff
(99.6 %id)
H17825 whole brain .g 1069 to 1399 354 to 22   tiling clone, AAA   333/337
(98 %)
1 diff
(99.8 %id)
BP299833   .h 1 to 579 1 to 579 exact tiling clone,   579/579
(100 %)
0 diff
(100 %id)
AA226480   .h 9 to 415 1 to 409       409/410
(99 %)
8 diff
(98.1 %id)
BG615822 embryonal carcinoma, testis .i 1 to 691 1 to 862 N2* tiling clone,   688/956
(71 %)
71 diff
(92.6 %id)
BU178342 melanotic melanoma, skin .i 21 to 713 1 to 693 exact tiling clone, AAA   693/693
(100 %)
0 diff
(100 %id)
CF124141 CNCAP(3)T-225 cell line, Prostate .j 1 to 523 36 to 558       524/572
(91 %)
7 diff
(98.8 %id)
CF124787 CNCAP(3)T-225 cell line, Prostate .j 1 to 523 36 to 558       524/572
(91 %)
6 diff
(99.0 %id)
TI_154184362   .j 1 to 523 97 to 619       524/909
(57 %)
7 diff
(99.3 %id)
BU953260 mixed (pool of 40 RNAs) .j 1 to 684 1 to 695 D151R D152*     691/755
(91 %)
21 diff
(97.3 %id)
CD641340 pooled .j 1 to 523 1 to 523   tiling clone,   523/695
(75 %)
1 diff
(99.9 %id)
CK004139 brain/CNS, Human Brain - Cerebellar Cortex .j 1 to 658 1 to 653 V158C     653/668
(97 %)
10 diff
(98.6 %id)
BU959593 mixed (pool of 40 RNAs) .j 2 to 523 1 to 522       522/822
(63 %)
3 diff
(99.7 %id)
BM773484 stomach .j 3 to 518 1 to 516       516/516
(100 %)
0 diff
(100 %id)
CB150619 cervix, Uterine .j 4 to 518 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BP259857 heart .j 4 to 569 1 to 566       566/566
(100 %)
9 diff
(98.5 %id)
CB116429 Liver .j 4 to 518 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BM839839 myeloma .j 4 to 518 1 to 515       515/515
(100 %)
0 diff
(100 %id)
DA822778 pericardium .j 5 to 523 2 to 520   capped   519/531
(97 %)
0 diff
(100 %id)
DA971037 synovial membrane tissue from rheumatioidarthritis .j 5 to 523 2 to 520   capped   519/538
(96 %)
0 diff
(100 %id)
BM782459 Ascites, stomach .j 6 to 518 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BM762023 myeloma .j 6 to 518 1 to 513       513/513
(100 %)
0 diff
(100 %id)
CD610307   .j 8 to 521 1 to 514       514/514
(100 %)
5 diff
(99.1 %id)
BM809354 amelanotic melanoma, cell line, skin .j 9 to 806 12 to 810 exact tiling clone,   799/812
(98 %)
3 diff
(99.7 %id)
BG490269 large cell carcinoma, lung .j 17 to 522 1 to 508       508/508
(100 %)
5 diff
(99.1 %id)
CB123803 Liver .j 17 to 523 1 to 507       507/527
(96 %)
1 diff
(99.9 %id)
BP420214 small intestine .j 22 to 520 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
CB119307 Liver .j 22 to 518 1 to 497       497/497
(100 %)
0 diff
(100 %id)
CN396971 embryonic stem cells, DMSO-treated H9 cellline .j 26 to 521 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BP420235 small intestine .j 26 to 523 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
CN397193 embryonic stem cells, DMSO-treated H9 cellline .j 45 to 519 1 to 475       475/475
(100 %)
0 diff
(100 %id)
CN397047 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 46 to 519 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BE256694 eye, retinoblastoma .j 49 to 523 7 to 479       474/479
(98 %)
8 diff
(98.4 %id)
BM907648 large cell carcinoma, lung .j 84 to 523 782 to 337   AAA Submitted on the opposite strand 446/1057
(42 %)
15 diff
(98.6 %id)
BQ343384 nervous_tumor .j 87 to 523 472 to 36       437/482
(90 %)
1 diff
(99.8 %id)
BE697260 colon .j 108 to 522 1 to 417       417/417
(100 %)
5 diff
(98.9 %id)
BQ312209 breast_normal .j 118 to 523 451 to 46       406/466
(87 %)
3 diff
(99.4 %id)
BQ317674 colon .j 131 to 522 1 to 392       392/392
(100 %)
3 diff
(99.3 %id)
CN397154 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 137 to 517 1 to 381       381/381
(100 %)
0 diff
(100 %id)
CB109425 Liver .j 152 to 531 1 to 380       380/385
(98 %)
6 diff
(98.5 %id)
BQ378142 uterus_tumor .j 157 to 523 1 to 368       366/534
(68 %)
4 diff
(99.3 %id)
CV337635 marrow .j 196 to 523 1 to 328       328/356
(92 %)
0 diff
(100 %id)
BQ360242 ovary .j 200 to 523 13 to 336       324/361
(89 %)
6 diff
(98.4 %id)
AA364388 pineal body .j 224 to 523 1 to 300       300/365
(82 %)
0 diff
(100 %id)
AJ710996 heart .j 239 to 764 15 to 539       525/539
(97 %)
6 diff
(98.9 %id)
BI030437 marrow .j 252 to 657 1 to 406       406/406
(100 %)
1 diff
(99.8 %id)
BQ335189 marrow .j 476 to 661 8 to 193       186/193
(96 %)
6 diff
(96.9 %id)
BU533862 mixed (pool of 40 RNAs) .k 1 to 770 1 to 771 N163X tiling clone,   771/779
(98 %)
15 diff
(98.1 %id)
BM809371 amelanotic melanoma, cell line, skin .k 15 to 769 22 to 776 exact tiling clone, AAA   755/776
(97 %)
5 diff
(99.4 %id)
BF311694 brain, neuroblastoma .k 16 to 767 1 to 754 exact AAA   754/756
(99 %)
8 diff
(99.0 %id)
CN397165 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 17 to 640 1 to 624 exact     624/624
(100 %)
2 diff
(99.7 %id)
BG519600 brain, neuroblastoma .k 18 to 762 1 to 753 R92T R94E S96I V97S R98S ...     753/791
(95 %)
19 diff
(97.6 %id)
BG519535 brain, neuroblastoma .k 18 to 770 1 to 754 K116Q G117R E118R K119E D120G ...     754/815
(92 %)
12 diff
(98.6 %id)
TI_59385283   .k 22 to 767 96 to 854 E91R R92K K93T K95E S96N ...     757/842
(89 %)
38 diff
(95.5 %id)
BM915336 amelanotic melanoma, cell line, skin .k 24 to 769 1 to 747 exact AAA   747/747
(100 %)
1 diff
(99.9 %id)
CA773915 Pancreas, Purified pancreatic islet .k 36 to 571 1 to 536   fully sequenced,   536/536
(100 %)
0 diff
(100 %id)
BE314171 brain, neuroblastoma .k 38 to 647 1 to 610 Q179H     610/610
(100 %)
1 diff
(99.9 %id)
BE783321 eye, retinoblastoma .k 39 to 769 1 to 727 A169G A170R Y171I C172A S173L ... AAA   727/727
(100 %)
10 diff
(98.7 %id)
AA843318 parathyroid gland, parathyroid tumor .k 159 to 769 630 to 22   AAA   609/726
(83 %)
3 diff
(99.6 %id)
AA846114 Spleen .k 243 to 767 538 to 14   AAA   525/527
(99 %)
0 diff
(100 %id)
AI831219 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .k 259 to 768 512 to 1       512/512
(100 %)
5 diff
(99.1 %id)
AW393586 stomach .k 436 to 732 17 to 312       296/315
(93 %)
14 diff
(95.6 %id)
AW393587 stomach .k 436 to 732 19 to 314       296/317
(93 %)
11 diff
(96.6 %id)
BQ363063 stomach .k 447 to 732 29 to 310       282/313
(90 %)
11 diff
(96.5 %id)
BU069187 Pancreas, Purified pancreatic islet .k 510 to 767 260 to 3   fully sequenced,   258/260
(99 %)
0 diff
(100 %id)
BU681740 lung .k 539 to 769 249 to 19   AAA   231/231
(100 %)
0 diff
(100 %id)
BP379107 uterus .l 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
BQ437260 eye, retinoblastoma .m 1 to 905 1 to 910   tiling clone,   910/910
(100 %)
18 diff
(98.1 %id)
BM451851 eye, retinoblastoma .m 876 to 1073 1 to 197   tiling clone, AAA   197/197
(100 %)
4 diff
(98.0 %id)
AV755838 bone marrow .m 883 to 1073 93 to 284   tiling clone, AAA   192/200
(96 %)
2 diff
(99.0 %id)
BF752328 breast_normal .m 889 to 1067 34 to 212       179/261
(68 %)
4 diff
(98.5 %id)
EC458321 Prostate .m 889 to 988 1 to 100       100/100
(100 %)
6 diff
(94.0 %id)
EC510561 Prostate .m 889 to 990 3 to 104       102/106
(96 %)
1 diff
(99.1 %id)
AA528474 Kidney .m 889 to 1071 11 to 193   AAA   183/195
(93 %)
2 diff
(99.0 %id)
AA507354 Prostate .m 889 to 1073 201 to 17   AAA   185/208
(88 %)
0 diff
(100 %id)
AA522753 metastatic prostate bone lesion .m 889 to 1074 194 to 9       186/218
(85 %)
0 diff
(100 %id)
AA523251 metastatic prostate bone lesion .m 889 to 1073 39 to 223   AAA   185/223
(82 %)
0 diff
(100 %id)
AA657576 alveolar rhabdomyosarcoma .m 889 to 1073 37 to 221   AAA   185/221
(83 %)
0 diff
(100 %id)
AA935057 metastatic prostate bone lesion .m 889 to 1073 30 to 214   AAA   185/214
(86 %)
2 diff
(99.1 %id)
AA886138 metastatic prostate bone lesion .m 889 to 1073 199 to 15   AAA   185/213
(86 %)
2 diff
(99.1 %id)
AA857502 ovary .m 889 to 1073 59 to 243   AAA Submitted on the opposite strand 185/243
(76 %)
0 diff
(100 %id)
BU535848 mixed (pool of 40 RNAs) .m 889 to 1074 30 to 215       186/249
(74 %)
2 diff
(99.2 %id)
BU564239 mixed (pool of 40 RNAs) .m 889 to 1073 39 to 224       186/261
(71 %)
3 diff
(98.9 %id)
BU928068 mixed (pool of 40 RNAs) .m 889 to 1073 11 to 195   AAA   185/195
(94 %)
0 diff
(100 %id)
BU963283 mixed (pool of 40 RNAs) .m 889 to 1072 6 to 189       184/226
(81 %)
1 diff
(99.6 %id)
AA357350   .m 894 to 1073 189 to 11   AAA   179/179
(100 %)
1 diff
(99.5 %id)
CD677833 eye, Trabecular meshwork .m 894 to 1073 1 to 180   AAA   180/180
(100 %)
0 diff
(100 %id)
AW438750 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m 895 to 1073 192 to 14   AAA   179/179
(100 %)
1 diff
(99.5 %id)
AA353256   .n 1 to 372 1 to 375   tiling clone,   375/383
(97 %)
6 diff
(98.5 %id)
DA943742 Spleen .n 303 to 860 2 to 559   tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
CN413162 embryonic stem cells, cell lines H1, H7, andH9 .n 588 to 1209 1 to 622   tiling clone,   622/622
(100 %)
2 diff
(99.7 %id)
AW663200 2 pooled high-grade transitional celltumors, genitourinary tract .n 825 to 1103 10 to 290   tiling clone,   281/290
(96 %)
6 diff
(98.0 %id)
AW205632   .n 1152 to 1658 524 to 18   AAA   507/507
(100 %)
3 diff
(99.5 %id)
AI859410 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n 1190 to 1661 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
AW074157 2 pooled high-grade transitional celltumors, genitourinary tract .n 1196 to 1660 465 to 1   tiling clone,   465/472
(98 %)
0 diff
(100 %id)
BQ955249 sciatic nerve .n 1239 to 2088 1 to 860   tiling clone,   860/882
(97 %)
28 diff
(96.9 %id)
AI336756 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 1242 to 1659 416 to 1       416/416
(100 %)
3 diff
(99.3 %id)
BX103215 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 1243 to 1672 430 to 1     Submitted on the opposite strand 430/430
(100 %)
0 diff
(100 %id)
CA337318 posterior rhombomeres 5-8 (4 pooled) .n 1386 to 1658 1 to 273   AAA   273/273
(100 %)
0 diff
(100 %id)
AW613640 2 pooled high-grade transitional celltumors, genitourinary tract .n 1423 to 1664 243 to 1       243/244
(99 %)
7 diff
(97.2 %id)
DW435297 Liver .n 1429 to 1659 14 to 244   AAA   231/245
(94 %)
2 diff
(99.2 %id)
DW437731 Liver .n 1429 to 1663 14 to 248       235/248
(94 %)
5 diff
(98.0 %id)
GD158888   .n 1546 to 1671 14 to 139       126/139
(90 %)
6 diff
(95.7 %id)
AW969732   .n 1725 to 2087 69 to 431       363/432
(84 %)
3 diff
(99.4 %id)
H67329 liver and spleen .n 1777 to 2195 1 to 423   tiling clone,   423/424
(99 %)
16 diff
(96.3 %id)
AA515741 liposarcoma .n 1784 to 2053 1 to 270       270/270
(100 %)
4 diff
(98.6 %id)
AW970974   .n 1785 to 2178 105 to 498   tiling clone,   394/613
(64 %)
12 diff
(98.1 %id)
BP392986 pancreatic islet .n 2173 to 2706 534 to 1   tiling clone,   534/534
(100 %)
0 diff
(100 %id)
AA484108 Ewing's sarcoma .n 2228 to 2707 502 to 23   tiling clone, AAA   480/481
(99 %)
0 diff
(100 %id)
H68536 liver and spleen .n 2299 to 2687 400 to 1       400/403
(99 %)
13 diff
(96.8 %id)
AA483380 Ewing's sarcoma .n 2348 to 2707 382 to 23   AAA   360/361
(99 %)
0 diff
(100 %id)
CK431180 eye, lacrimal gland .o 1 to 397 1 to 397 exact tiling clone,   397/397
(100 %)
0 diff
(100 %id)
DA198240 brain .p 1 to 533 2 to 536 exact tiling clone, capped   535/535
(100 %)
4 diff
(99.3 %id)
BG771587 testis .p 33 to 761 1 to 728 V49L D50T K51N L52C L53C ...     728/728
(100 %)
15 diff
(98.0 %id)
DA541803 lung .p 39 to 551 2 to 514 exact capped   513/513
(100 %)
0 diff
(100 %id)
DA582927 lung .p 39 to 637 2 to 602 A38C D39L A40T G42W E43V ... capped   601/601
(100 %)
5 diff
(99.2 %id)
DA589002 lung .p 39 to 619 2 to 582 exact capped   581/581
(100 %)
1 diff
(99.9 %id)
DA933628 Spleen .p 39 to 551 2 to 514 exact capped   513/513
(100 %)
0 diff
(100 %id)
DA976079 synovial membrane tissue from rheumatioidarthritis .p 39 to 593 2 to 556 N62D capped   555/555
(100 %)
1 diff
(99.9 %id)
DB186695 liver, tumor tissue .p 39 to 606 2 to 569 exact capped   568/568
(100 %)
1 diff
(99.9 %id)
DB257302 uterus .p 39 to 615 2 to 578 exact capped   577/577
(100 %)
0 diff
(100 %id)
DB273247 uterus .p 39 to 596 2 to 559 exact capped   558/558
(100 %)
1 diff
(99.9 %id)
DA374785 thalamus .p 40 to 594 2 to 556 exact capped   555/555
(100 %)
0 diff
(100 %id)
CB151877 cervix, Uterine .p 40 to 698 1 to 659 exact     659/659
(100 %)
0 diff
(100 %id)
DA818648   .p 40 to 601 2 to 563 G11A C12A Q13R K14N L15S ... capped   562/562
(100 %)
4 diff
(99.3 %id)
DB106974 thymus .p 41 to 612 2 to 573 exact capped   572/572
(100 %)
0 diff
(100 %id)
DB266793 uterus .p 43 to 635 2 to 594 exact capped   593/593
(100 %)
0 diff
(100 %id)
CN297731 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 45 to 698 1 to 654 L86F     654/654
(100 %)
4 diff
(99.4 %id)
N85398   .p 50 to 240 1 to 187       187/187
(100 %)
15 diff
(92.0 %id)
CN297732 embryonic stem cells, DMSO-treated H9 cellline .p 53 to 637 1 to 585 exact     585/585
(100 %)
1 diff
(99.9 %id)
BQ705934 Spleen .p 57 to 929 1 to 874 exact tiling clone,   874/874
(100 %)
8 diff
(99.1 %id)
AA386212 Pancreas .p 66 to 430 1 to 368 W78L L79A L80S T81D F82L ...     368/368
(100 %)
6 diff
(98.4 %id)
CN297734 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 314 to 971 1 to 659   tiling clone,   659/659
(100 %)
1 diff
(99.9 %id)
FN061307 breast carcinoma .p 478 to 588 112 to 1     Submitted on the opposite strand 112/112
(100 %)
2 diff
(98.3 %id)
DB303854 brain .p 1769 to 2294 526 to 1   tiling clone,   526/526
(100 %)
0 diff
(100 %id)
R08254 liver and spleen .q-u 1 to 286 1 to 296   tiling clone,   296/298
(99 %)
12 diff
(96.0 %id)
N47429 multiple sclerosis lesions .q-u 396 to 887 490 to 1 I2E E3S S4L F5E E6F ... tiling clone,   490/492
(99 %)
12 diff
(97.6 %id)
N67970 cochlea, ear .q-u 473 to 887 421 to 1   tiling clone,   421/422
(99 %)
7 diff
(98.4 %id)
AW009852 colon .q-u 533 to 888 359 to 4   tiling clone,   356/359
(99 %)
0 diff
(100 %id)
R08203 liver and spleen .q-u 575 to 888 318 to 2       317/319
(99 %)
0 diff
(100 %id)
FN117140 breast carcinoma .q-u 652 to 742 1 to 88       88/89
(98 %)
5 diff
(94.4 %id)
DA486693 brain .r-u 1 to 571 2 to 573 exact tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
CN297733 embryonic stem cells, cell lines H1, H7, andH9 .r-u 122 to 733 1 to 611 exact tiling clone,   611/612
(99 %)
2 diff
(99.7 %id)
EL952281 eyeball .s 1 to 511 40 to 550 exact tiling clone,   524/555
(94 %)
6 diff
(99.0 %id)
TI_149271077   .s 46 to 500 538 to 83 exact AAA   456/1041
(43 %)
1 diff
(100.0 %id)
GD160660.
matches multiple genes
  P1.a-u 242 to 324 1 to 85     also hits gene RPS6P1 85/96
(88 %)
15 diff
(84.4 %id)
AA886613.
matches multiple genes
metastatic prostate bone lesion P10.a-u 1223 to 1357 1 to 135   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, also hits gene RPS6P10 135/142
(95 %)
11 diff
(92.3 %id)
EC456102.
matches multiple genes
Prostate P10.a-u 1530 to 1632 8 to 111     also hits gene RPS6P10 104/112
(92 %)
6 diff
(94.7 %id)
EC486065.
matches multiple genes
Prostate P10.a-u 1548 to 1648 11 to 111     also hits gene RPS6P10 101/111
(90 %)
6 diff
(94.6 %id)
EC466350 Prostate Gene RPS6, variant not shown         This clone was ignored    
EC557236 Prostate Gene RPS6, variant not shown         Suspected internal deletion, this clone was ignored    
AW389822 stomach Gene RPS6, variant not shown         Suspected internal deletion, this clone was ignored    
451 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r-u, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI